Skip to content
Homepage
Author:
Vivani Medical, Inc.
Posted Date:
June 26, 2026
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
Vivani Medical, Inc.
June 26, 2026
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
Vivani Medical, Inc.
June 25, 2026
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
Vivani Medical, Inc.
June 22, 2026
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
Vivani Medical, Inc.
May 28, 2026
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
Vivani Medical, Inc.
May 13, 2026
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
Vivani Medical, Inc.
January 29, 2026
Vivani Medical, Inc. Announces Closing of Common Stock Offering
Vivani Medical, Inc.
January 28, 2026
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
Vivani Medical, Inc.
January 28, 2026
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
Vivani Medical, Inc.
January 27, 2026
